Day: May 7, 2020

Maxim Power Corp. Announces 2020 First Quarter Financial and Operating Results

CALGARY, Alberta, May 07, 2020 (GLOBE NEWSWIRE) — Maxim Power Corp. (“MAXIM” or the “Corporation”) (TSX: MXG) announced today the release of financial and operating results for the first quarter ended March 31, 2020. The unaudited condensed consolidated interim financial statements, accompanying notes and Management’s Discussion and Analysis (“MD&A”) will be available on SEDAR and on MAXIM’s website on May 7, 2020. All figures reported herein are Canadian dollars unless otherwise stated.OPERATING RESULTSAdjusted EBITDA and net income increased in the first quarter of 2020 when compared to 2019, primarily due to realizing power prices of $171.45 per MWh in 2020, as compared to $67.29 per MWh in 2019, fuel and carbon tax savings as a result of lower generation volumes, lower operations and maintenance...

Continue reading

CORRECTION – Apollo Commercial Real Estate Finance, Inc. Reports First Quarter 2020 Results

NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) — In a release under the same headline issued earlier today by Apollo Commercial Real Estate Finance, Inc. (NYSE:ARI), please note that in the fifth paragraph, the time of the earnings teleconference call has been corrected to 9:00 a.m. on Friday, May 8, 2020, not 10:00 a.m. as previously stated. The corrected release follows:Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today reported results for the quarter ended March 31, 2020. First quarter 2020 net loss per share of common stock was $0.86 and Operating Earnings (a non-GAAP financial measure defined below) per share of common stock was $0.40. “I am extremely proud of the hard work, perseverance and dedication of the team at our Manager, ACREFI Management, LLC, an indirect subsidiary of Apollo Global Management,...

Continue reading

Almadex Minerals Ltd. Grants Stock Options

VANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: DEX) announces that, pursuant to its Stock Option Plan, it has granted stock options to certain directors, employees, and consultants of the Company to purchase an aggregate 425,000 common shares in the capital of the Company at an exercise price of $0.19 per share which expire on May 9, 2022.About AlmadexAlmadex Minerals Ltd. is an exploration company that holds a large mineral portfolio consisting of projects and NSR royalties in Canada, the U.S., and Mexico. This portfolio is the direct result of over 35 years of prospecting and deal-making by Almadex’s management team. Almadex owns a number of portable diamond drill rigs, enabling it to conduct cost effective first pass exploration...

Continue reading

HC2 Holdings Advises Stockholders to Revoke Their Consents to Percy Rockdale’s Proposals

HC2 Recommends Stockholders Sign, Date and Promptly Return the WHITE Consent Revocation Card and Mark “REVOKE MY CONSENT” Boxes to Oppose Each of Percy Rockdale’s Proposals and Support HC2’s Independent, Experienced and Highly-Qualified DirectorsHC2 Advises Stockholders to Vote For HC2’s Full Slate of Directors at HC2’s 2020 Annual Meeting of StockholdersNEW YORK, May 07, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE: HCHC), a diversified holding company, today reminded stockholders to review HC2’s extensive board refreshment, stockholder engagement and voluntary compensation reductions, before making a considered judgment on Board composition at the Company’s 2020 Annual Meeting of Stockholders (the “2020 Annual Meeting”). The Company strongly advises that stockholders refrain from committing to a hasty...

Continue reading

Novant Health Initiates Phase 2b/3 Trial with CytoDyn’s Leronlimab for Severely and Critically Ill COVID-19 Patients

VANCOUVER, Washington and WINSTON-SALEM, N.C., May 07, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Novant Health is initiating patient enrollment in CytoDyn’s Phase 2b/3 trial for severely and critically ill COVID-19 patients.Leronlimab has been administered to 54 severely and critically ill COVID-19 patients thus far under Emergency Investigational New Drug (EINDs) authorizations granted by the U.S. Food and Drug Administration (FDA).  Preliminary results from this patient population led to the FDA’s recent clearance for CytoDyn’s Phase 2b/3 clinical trial for 390 patients, which is randomized, placebo-controlled with 2:1...

Continue reading

Junshi Biosciences Announces Acceptance of a Supplemental NDA in China for Toripalimab in Locally Advanced or Metastatic Urothelial Carcinoma

SHANGHAI, China, May 07, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877) a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, today announced that the China National Medical Products Administration (NMPA) has accepted a supplemental New Drug Application (sNDA) for toripalimab as a 2nd line treatment for patients with locally advanced or metastatic urothelial carcinoma who have received systemic therapy.Urothelial carcinoma is the most common (more than 90%) histologic type of bladder cancer in China. Bladder cancer incidence is estimated to be 80,000 cases per year in the country. It ranked ninth for all cancer deaths in China, accounting for about 14% of bladder cancer deaths worldwide.The sNDA is based on the results of POLARIS-03 study...

Continue reading

Alliant Energy Announces First Quarter 2020 Results

MADISON, Wis., May 07, 2020 (GLOBE NEWSWIRE) — Alliant Energy Corporation (NASDAQ: LNT) today announced U.S. generally accepted accounting principles (GAAP) and non-GAAP consolidated unaudited earnings per share (EPS) for the three months ended March 31 as follows:“In this uncertain environment of the global COVID-19 pandemic, our company continues to focus on providing the critical, reliable service our customers depend on, while emphasizing the health and welfare of our employees, customers and communities,” said John Larsen, Alliant Energy Chairman, President and CEO.  “Based upon our forecasted impacts of COVID-19, and planned mitigation measures, we are reaffirming 2020 earnings guidance of $2.34 to $2.48 per share.”Utilities and Corporate Services – Alliant Energy’s Utilities and Alliant Energy Corporate Services, Inc....

Continue reading

UPDATE — Infrastructure and Energy Alternatives, Inc. Announces First Quarter 2020 Financial Results

INDIANAPOLIS, May 07, 2020 (GLOBE NEWSWIRE) — Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) (“IEA” or the “Company”), a leading infrastructure construction company with renewable energy and specialty civil expertise, today announced its financial results for the quarter ended March 31, 2020.Quarter HighlightsRevenue totaled $358.2 million, an increase of 88.7% as compared to the prior-year period.Gross margin of 9.2%, as compared to 3.0% over the prior-year period.Backlog of $2.0 billion provides strong visibility.Cash and cash equivalents of $58.1 million at March 31, 2020 and no long-term debt amortization payments due until 2022.To date, the Company has had no negative material impact from COVID-19 and is reiterating its current 2020 revenue and Adjusted EBITDA guidance.Management Commentary“IEA is considered a provider...

Continue reading

Enerflex Announces First Quarter 2020 Financial Results and Quarterly Dividend

CALGARY, Alberta, May 07, 2020 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX:EFX) (“Enerflex” or “the Company” or “we” or “our”), a leading supplier of products and services to the global energy industry, today reported its financial and operating results for the three months ended March 31, 2020.“While continuing to prioritize the health and safety of our employees, clients and suppliers, we are proud to say that all of Enerflex’s manufacturing facilities, rental, BOOM, and Service operations are open and have been operational since the beginning of the COVID-19 pandemic. Throughout these challenging times, Enerflex employees have kept natural gas, natural gas liquids, and electricity flowing for the benefit of our clients,” said Marc Rossiter, Enerflex’s President and Chief Executive Officer. “Enerflex is a highly globalized company that...

Continue reading

Ero Copper Announces First Quarter Results, Improved Operating and Capital Cost Guidance for 2020

(all amounts in US dollars, unless otherwise noted)VANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) — Ero Copper Corp. (the “Company”) (TSX: ERO) today is pleased to announce its financial results for the three months ended March 31, 2020. Management will host a conference call tomorrow, Friday, May 8, 2020, at 11:30 a.m. Eastern to discuss the results.  Dial-in details for the call can be found near the end of this press release.HIGHLIGHTSFirst quarter copper production of 10,657 tonnes of copper;Record C1 cash costs* of $0.71 per pound of copper produced contributing to record quarterly cash flow from operations of $37.3 million during the three month period ended March 31, 2020;First quarter gold and silver production at the NX Gold Mine of 7,866 ounces of gold and 4,868 ounces of silver at C1 cash costs* of $594 per...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.